Schram A W, Goldfischer S, van Roermund C W, Brouwer-Kelder E M, Collins J, Hashimoto T, Heymans H S, van den Bosch H, Schutgens R B, Tager J M
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2494-6. doi: 10.1073/pnas.84.8.2494.
We investigated the peroxisomal beta-oxidation system in liver from a patient with clinical features similar to those in the cerebrohepatorenal (Zellweger) syndrome and with elevated levels in body fluids of very-long-chain fatty acids and intermediates in the biosynthesis of bile acids. The peroxisomal beta-oxidation of fatty acids, measured as the cyanide-insensitive formation of [14C]acetyl units from [14C]palmitoyl-CoA, was very low in the patient (less than 10% of the values in control subjects). Immunoblotting experiments using antibodies to peroxisomal beta-oxidation enzymes indicated that peroxisomal 3-oxoacyl-CoA thiolase (acyl-CoA:acetyl-CoA C-acyltransferase, EC 2.3.1.16) was deficient. Addition of purified rat-liver peroxisomal 3-oxoacyl-CoA thiolase to a reaction mixture containing liver homogenate from the patient restored peroxisomal beta-oxidation. We conclude that the deficiency of peroxisomal 3-oxoacyl-CoA thiolase is responsible for the very low peroxisomal beta-oxidation activity and for the accumulation of very-long-chain fatty acids and intermediates in the biosynthesis of bile acids. Furthermore, the finding that both very-long-chain fatty acids and abnormal bile acids accumulate in this patient suggests that a single peroxisomal 3-oxoacyl-CoA thiolase is involved in the oxidative chain shortening of both very-long-chain fatty acids and the coprostanoic acids.
我们研究了一名患者肝脏中的过氧化物酶体β-氧化系统。该患者具有与脑肝肾(泽尔韦格)综合征相似的临床特征,其体液中极长链脂肪酸和胆汁酸生物合成中间体水平升高。以[14C]棕榈酰辅酶A生成对氰化物不敏感的[14C]乙酰单位来衡量,该患者脂肪酸的过氧化物酶体β-氧化非常低(不到对照受试者值的10%)。使用针对过氧化物酶体β-氧化酶的抗体进行的免疫印迹实验表明,过氧化物酶体3-氧代酰基辅酶A硫解酶(酰基辅酶A:乙酰辅酶A C-酰基转移酶,EC 2.3.1.16)缺乏。向含有该患者肝脏匀浆的反应混合物中添加纯化的大鼠肝脏过氧化物酶体3-氧代酰基辅酶A硫解酶可恢复过氧化物酶体β-氧化。我们得出结论,过氧化物酶体3-氧代酰基辅酶A硫解酶的缺乏是过氧化物酶体β-氧化活性极低以及胆汁酸生物合成中极长链脂肪酸和中间体积累的原因。此外,该患者体内极长链脂肪酸和异常胆汁酸均积累这一发现表明,单一的过氧化物酶体3-氧代酰基辅酶A硫解酶参与了极长链脂肪酸和粪甾烷酸的氧化链缩短过程。